Accessibility Menu
Imagenetix logo

Imagenetix(OTC) IAGX

Market Cap$5.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2000)-100%
5 Year-97%
1 Year+19,900%
1 Month+0%
$0.00
+0.00%
+0.00Today
Imagenetix last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-20
Imagenetix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-05-19
1 month+0%USD 0.002026-05-19
3 month+19,900%USD 0.002025-12-09
Year to date+19,900%USD 0.002025-12-09
1 year+19,900%USD 0.002025-07-18
3 year+0%USD 0.002023-06-30
5 year-97.14%USD 0.012021-07-19
Since inception-99.99%USD 1.752000-10-25

Imagenetix Financials at a Glance

Market Cap

$5.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.92M

Net Income (TTM)

-$3.27M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

54.17 (High)

Price

$0.00

Volume

800

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

IAGX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imagenetix

Imagenetix, Inc. is a healthcare company based in San Diego, California, specializing in the development and distribution of natural-ingredient nutritional supplements and topical skincare solutions. Established in 1996, the company is known for its flagship product, Celadrin, which promotes joint health and well-being.

Products and Services
  • Celadrin, a specialized formulation for joint health
  • Natural-ingredient nutritional supplements
  • Non-prescription topical creams and skincare solutions
Growth Outlook
  • Recent revenue of $377,515 shows potential for growth
  • Gross profit margin of 75.58% indicates strong product demand
  • Licensing proprietary technologies can enhance revenue streams
Financial Highlights
  • Trailing twelve months (TTM) revenue of $1,000,000 reflects stability
  • Current ratio of 0.69 suggests manageable short-term liabilities
  • Net income margin of -2.63% indicates room for operational improvement
Imagenetix, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, focusing on innovative health solutions. The company has a diverse marketing strategy, reaching customers through various channels, including health professionals and direct-response campaigns. The recent quarterly revenue indicates a positive trend, while the gross profit margin suggests that the products are well-received in the market. The company's ability to license its technologies may provide additional revenue opportunities, further enhancing its growth potential. Financially, the current ratio indicates that the company can cover its short-term obligations, while the net income margin highlights areas for operational enhancement. Overall, Imagenetix, Inc. presents an intriguing opportunity for investors interested in the healthcare sector.
AI Generated • Aug 4, 2026

Industry

Personal Products

Headquarters

San Diego, CA 92127, US

IAGX Financials

Key Financial Metrics (TTM)

Gross Margin

41.59%

Operating Margin

1.74%

Net Income Margin

-2.63%

Return on Equity

-3.39%

Return on Capital

0.23%

Return on Assets

-0.25%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

28.42M

Volume

800

Avg. Volume

15.873

Financials (TTM)

Gross Profit

$1.46M

Operating Income

-$122.33K

EBITDA

-$592.30K

Operating Cash Flow

$244.73K

Capital Expenditure

$0.00

Free Cash Flow

$244.73K

Cash & ST Invst.

$92.39K

Total Debt

$0.00

Imagenetix Performance Analysis

Imagenetix sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32011-12-31-53.9%
Q22014-09-30N/A
Q32014-12-31N/A
Q12015-06-30N/A
Imagenetix sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32011-12-3192.3%
Q22014-09-30N/A
Q32014-12-31N/A
Q12015-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2015YOY CHG

Revenue

$377.52K

-30.7%

Gross Profit

$285.33K

+31.8%

Gross Margin

75.58%

N/A

Market Cap

$5.70KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.14K

N/A

Employees

5

N/A

Net Income

-$48.78K

+88.0%

EBITDA

-$49.02K

+91.9%

Quarterly Fundamentals

Name
Q1 2015YOY CHG

Total Cash

$92.39K

-73.3%

Total Debt

$0.00

-100.0%

Accounts Receivable

$383.14K

-56.3%

Inventory

$115.15K

-82.7%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

-100.0%

Return on Assets

-0.25%

N/A

Return on Invested Capital

0.18%

N/A

Free Cash Flow

-$6.28K

-101.4%

Operating Cash Flow

-$6.28K

-101.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CVHIFVentura Cannabis & Wellness Corporation
$0.00+0.00%
SYVCSynovics Pharmaceuticals, Inc.
$0.00+0.00%
NLVVFNew Leaf Ventures Inc
$0.00+0.00%
NTIINeurobiological Technologies, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About IAGX

What is the current price of Imagenetix?

Imagenetix is trading at $0.00 per share.

What is the 52-week range for Imagenetix?

Over the past 52 weeks, Imagenetix has traded between $0.00 and $0.00.

How much debt does Imagenetix have?

Imagenetix total debt is unavailable.

How much cash does Imagenetix have on hand?

Imagenetix does not have cash on hand data available.

What is Imagenetix’s dividend yield?

Imagenetix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.